Literature DB >> 33481031

Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name Medications for Common Conditions From 2015 to 2020.

Patrick Liu1, Sanket S Dhruva2,3, Nilay D Shah4, Joseph S Ross5.   

Abstract

Entities:  

Year:  2021        PMID： 33481031      PMCID： PMC7823226          DOI： 10.1001/jamanetworkopen.2020.35064

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN： 2574-3805


× No keyword cloud information.
  3 in total

Review 1.  Insulin Access and Affordability Working Group: Conclusions and Recommendations.

Authors:  William T Cefalu; Daniel E Dawes; Gina Gavlak; Dana Goldman; William H Herman; Karen Van Nuys; Alvin C Powers; Simeon I Taylor; Alan L Yatvin
Journal:  Diabetes Care       Date:  2018-05-08       Impact factor: 19.112

2.  Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018.

Authors:  Inmaculada Hernandez; Alvaro San-Juan-Rodriguez; Chester B Good; Walid F Gellad
Journal:  JAMA       Date:  2020-03-03       Impact factor: 56.272

3.  Competition and price among brand-name drugs in the same class: A systematic review of the evidence.

Authors:  Ameet Sarpatwari; Jonathan DiBello; Marie Zakarian; Mehdi Najafzadeh; Aaron S Kesselheim
Journal:  PLoS Med       Date:  2019-07-30       Impact factor: 11.069
  3 in total
  2 in total

1.  Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019.

Authors:  Tianna Zhou; Patrick Liu; Sanket S Dhruva; Nilay D Shah; Reshma Ramachandran; Karina M Berg; Joseph S Ross
Journal:  JAMA Intern Med       Date:  2022-02-01       Impact factor: 44.409

2.  National Trends in Use of and Spending on Oral Anticoagulants Among US Medicare Beneficiaries From 2011 to 2019.

Authors:  Aaron Troy; Timothy S Anderson
Journal:  JAMA Health Forum       Date:  2021-07-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.